Literature DB >> 28864936

A Case of Cutaneous Mycosis Caused by Scedosporium dehoogii on an Immunocompromised Patient.

Yuichi Sakata1, Fumiaki Taga1, Tsuyoshi Ushigami1, Kiminobu Takeda1, Kazushi Anzawa1, Akiko Nishibu1, Takashi Mochizuki2.   

Abstract

This report describes a 77-year-old man with cutaneous mycosis caused by Scedosporium dehoogii while taking oral betamethasone and tacrolimus for the treatment of rheumatoid arthritis. At examination in our clinic, the patient had multiple cystic lesions and nodules with slight tenderness, varying in size up to 4 cm, on his left knee and shin. He had not noticed any traumatic injury at the site of the lesions. Fungal cultures of samples taken from the abscesses, scales, and crusts of the lesions yielded white, later grayish brown, fluffy surfaced colonies. Partial sequencing of the β-tubulin gene confirmed the species of the isolate. The patient was initially treated with oral voriconazole and local hyperthermia, but experienced hepatic injury 2 weeks later. His treatment was changed to itraconazole (ITC) and local hyperthermia, followed by a combination of ITC and terbinafine. The patient recovered completely during the 12-month course of treatment.

Entities:  

Keywords:  Cutaneous infection; Immunocompromised patient; Itraconazole; Scedosporium dehoogii; Terbinafine; Voriconazole

Mesh:

Substances:

Year:  2017        PMID: 28864936     DOI: 10.1007/s11046-017-0198-5

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  9 in total

1.  Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species.

Authors:  Felix Gilgado; Josep Cano; Josepa Gené; Josep Guarro
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Spontaneous Remission of Subcutaneous Scedosporiosis Caused by Scedosporium dehoogii in a Psoriatic Patient.

Authors:  Fang-Gu Li; Yan-Ping Yang; Wei Li; Ping Sheng; Wen Li; Wen-Ming Huang; Yi-Ming Fan
Journal:  Mycopathologia       Date:  2017-01-10       Impact factor: 2.574

3.  Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.

Authors:  Michaela Lackner; G Sybren de Hoog; Paul E Verweij; Mohammad J Najafzadeh; Ilse Curfs-Breuker; Corné H Klaassen; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

4.  Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population.

Authors:  T Kubota; K Chiba; T Ishizaki
Journal:  Clin Pharmacol Ther       Date:  1996-12       Impact factor: 6.875

5.  Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii.

Authors:  Fèlix Gilgado; Josep Cano; Josepa Gené; Deanna A Sutton; Josep Guarro
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

6.  Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.

Authors:  Peter Troke; Koldo Aguirrebengoa; Carmen Arteaga; David Ellis; Christopher H Heath; Irja Lutsar; Montserrat Rovira; Quoc Nguyen; Monica Slavin; Sharon C A Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

7.  In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.

Authors:  Kazuaki Matsumoto; Kazuro Ikawa; Kazuko Abematsu; Naoko Fukunaga; Kentaro Nishida; Tomohide Fukamizu; Yoshihiro Shimodozono; Norifumi Morikawa; Yasuo Takeda; Katsushi Yamada
Journal:  Int J Antimicrob Agents       Date:  2009-03-03       Impact factor: 5.283

9.  Susceptibility and diversity in the therapy-refractory genus scedosporium.

Authors:  M Lackner; F Hagen; J F Meis; A H G Gerrits van den Ende; D Vu; V Robert; J Fritz; T A A Moussa; G S de Hoog
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

  9 in total
  1 in total

1.  Fungal osteomyelitis and septic arthritis in an immune competent man: The first report of invasive osteoarticular infection due to Scedosporium dehoogii.

Authors:  Daniel S Krauth; Brian T Barlow; Catherine M Berjohn
Journal:  Med Mycol Case Rep       Date:  2021-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.